Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Gomez-Galeno

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|June 26, 2026
Antibody-Assisted Protection from Paraoxon and Nerve Agent Model CompoundsCharles M Thompson, Jorge Gomez-Galeno, John R Cashman
Pharmacology Research & Perspectives|July 30, 2021
Human-induced pluripotent stem cell-derived cardiomyocytes: Cardiovascular properties and metabolism and pharmacokinetics of deuterated mexiletine analogsJorge Gomez-Galeno, Karl Okolotowicz, Mark Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 5, 2019
A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate CancerJiongjia Cheng, Stephanie Moore, Jorge Gomez-Galeno, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2021
Human iPSC-derived cardiomyocytes and pyridyl-phenyl mexiletine analogsMark Johnson, Jorge Gomez-Galeno, Daniel Ryan, et al.
Journal of Medicinal Chemistry|May 4, 2021
Antiarrhythmic Hit to Lead Refinement in a Dish Using Patient-Derived iPSC CardiomyocytesJohn R Cashman, Daniel Ryan, Wesley L McKeithan, et al.
Journal of the American Chemical Society|April 22, 2004
Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liverMark D Erion, K Raja Reddy, Serge H Boyer, et al.
Scientific Reports|July 27, 2019
Disruption of NOTCH signaling by a small molecule inhibitor of the transcription factor RBPJCecilia Hurtado, Alena Safarova, Michael Smith, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|June 26, 2026
Antibody-Assisted Protection from Paraoxon and Nerve Agent Model CompoundsCharles M Thompson, Jorge Gomez-Galeno, John R Cashman
Pharmacology Research & Perspectives|July 30, 2021
Human-induced pluripotent stem cell-derived cardiomyocytes: Cardiovascular properties and metabolism and pharmacokinetics of deuterated mexiletine analogsJorge Gomez-Galeno, Karl Okolotowicz, Mark Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 5, 2019
A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate CancerJiongjia Cheng, Stephanie Moore, Jorge Gomez-Galeno, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2021
Human iPSC-derived cardiomyocytes and pyridyl-phenyl mexiletine analogsMark Johnson, Jorge Gomez-Galeno, Daniel Ryan, et al.
Journal of Medicinal Chemistry|May 4, 2021
Antiarrhythmic Hit to Lead Refinement in a Dish Using Patient-Derived iPSC CardiomyocytesJohn R Cashman, Daniel Ryan, Wesley L McKeithan, et al.
Journal of the American Chemical Society|April 22, 2004
Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liverMark D Erion, K Raja Reddy, Serge H Boyer, et al.
Scientific Reports|July 27, 2019
Disruption of NOTCH signaling by a small molecule inhibitor of the transcription factor RBPJCecilia Hurtado, Alena Safarova, Michael Smith, et al.
Pageof 1